TNFα-antagonist use and mucosal inflammation are associated with increased intestinal expression of SARS-CoV-2 host protease TMPRSS2 in patients with inflammatory bowel disease

Posted on June 15, 2020 by Gastroenterology Journal
This entry was posted in News. Bookmark the permalink.